December 3, 2020
On Tuesday, December 8 at 11am ET, the International AIDS Society’s Towards an HIV Cure initiative is hosting a webinar, Paving the way for an HIV cure: Introducing Target Product Profiles (TPP) and the HIV Cure Africa Acceleration Partnership (HCAAP), to unpack two new articles just published in The Lancet HIV.
The articles argue why now is the time to focus on advancing HIV cure research. Outputs of a 2019 meeting of global stakeholders, these articles—The case for an HIV cure and how to get there and Multi Stakeholder Consensus on a Target Product Profile for an HIV Cure—make the case for the role an HIV cure can play in ending the epidemic, and share a roadmap to get there, including the role of community advocates.
As described in the articles and to be discussed on next week’s webinar, there is a need now for community advocates to provide input on acceptability of potential cure interventions, help to shape the policy environment, and enhance the capacity needed for cure trials, such as robust HIV and viral load testing. To that end, the proposed HCAAP plans to coordinate key stakeholders (e.g., regulators, funders, civil society, Ministries Of Health, researchers, etc.) across the public and private sectors to drive the development of a community-led cure research agenda and speed up access to a potential strategy in the future.
The companion article describes how multiple stakeholders came together to develop a TPP for an HIV cure strategy in Africa. A TPP is a living document that sets goal posts for what an ideal and acceptable product might look like for a specific population, which gives researchers, product developers, policy makers and advocates a roadmap to develop a strategy that can be delivered right away.
We hope you will join next week’s conversation and happy reading!